Clinical Trial Update: Dabigatran Treatment Following Transient Ischemic Attack and Minor Stroke [Phase 2]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 2 study evaluating dabigatran for secondary prevention after transient ischemic attack or minor isc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: University of Alberta | Conditions: Transient Ischemic Attack, Minor Ischemic Stroke | Phase 2 | Status: COMPLETED